Author

Baled I. Khalefa

Observed names: B. Khalefa, B.I. Khalefa, Baled. I. Khalefa, Baled.I. Khalefa, Khalefa, Baled

Institutions: Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Zintan University, Freie Universität Berlin, Charité – Universitätsmedizin Berlin

Observed institutions: Humboldt-Universität zu Berlin, Jena University Hospital, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Zintan University, Stiftung Charité, Freie Universität Berlin, Friedrich Schiller University Jena, Charité – Universitätsmedizin Berlin, Ludwig-Maximilians-Universität München

OpenAlex ID: A5023237079

Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids

2011 · B.I. Khalefa, M. Shaqura, et al. · European Journal of Pain · 56

Rab7 Silencing Prevents μ-Opioid Receptor Lysosomal Targeting and Rescues Opioid Responsiveness to Strengthen Diabetic Neuropathic Pain Therapy

2012 · Shaaban A. Mousa, Mohammed Shaqura, et al. · Diabetes · 44

Reduced Number, G Protein Coupling, and Antinociceptive Efficacy of Spinal Mu-Opioid Receptors in Diabetic Rats Are Reversed by Nerve Growth Factor

2013 · Mohammed Shaqura, Baled I. Khalefa, et al. · Journal of Pain · 37

New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy

2014 · Mohammed Shaqura, Baled.I. Khalefa, et al. · Neuropharmacology · 31

Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes

2015 · Shaaban A. Mousa, Mohammed Shaqura, et al. · Pain · 29

Peripheral antinociceptive efficacy and potency of a novel opioid compound 14- O -MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain

2013 · Baled. I. Khalefa, Shaaban A. Mousa, et al. · European Journal of Pharmacology · 22

Accessibility of axonal G protein coupled mu-opioid receptors requires conceptual changes of axonal membrane targeting for pain modulation

2017 · Shaaban A. Mousa, Mohammed Shaqura, et al. · Journal of Controlled Release · 17

Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

2022 · Shaaban A. Mousa, Baled I. Khalefa, et al. · Journal of Neuroinflammation · 8

Functional and Anatomical Characterization of Corticotropin-Releasing Factor Receptor Subtypes of the Rat Spinal Cord Involved in Somatic Pain Relief

2021 · Shaaban A. Mousa, Mohammed Shaqura, et al. · Molecular Neurobiology · 8

Opioid receptor efficacy during normal and pathological conditions

2014 · Khalefa, Baled · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver

T631 Superior Antinociception of Centrally Penetrating Opioids Fentanyl and Morphine Over the Peripherally Restricted Opioid Loperamide in Pain Modulation

2011 · B. Khalefa, M. Shaqura, et al. · European Journal of Pain Supplements

T261 Impaired Opioid Responsiveness Following Diabetic Neuropathic Pain Is Due to Enhanced Rab7-mediated Lysosomal Degradation of Sensory Neuron Mu-opioid Receptors

2011 · S. Mousa, M. Shaqura, et al. · European Journal of Pain Supplements

S128 Functional and Anatomical Characterization of Corticotropin-releasing Factor Receptor Subtypes of Rat Spinal Cord Involved in the Modulation of Inflammatory Pain

2011 · M. Shaqura, S. Mousa, et al. · European Journal of Pain Supplements

F105 Impaired Opioid Receptor Expression, Coupling and Efficacy in Spinal Cord Sensory Neurons of Rats With Streptozotocin-induced Diabetic Neuropathic Pain

2011 · M. Shaqura, B. Khalefa, et al. · European Journal of Pain Supplements

Works count: 14

Citation count: 252

H-index: 8

I10-index: 7